Brought to you by 
Marinus Pharmaceuticals gets $29.4mm with Series A round
02 Nov 2005
Executive Summary
Drug development company Marinus Pharmaceuticals has closed a $29.4mm Series A round led by Domain Associates, Sofinnova Ventures, and Canaan Partners. Also participating in the financing were Foundation Medical Partners and private investors.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Marinus Pharmaceuticals gets $29.4mm with Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice